Trial Profile
An Open-Label, Randomized, Single-Dose Study to Evaluate the Effects of 325 mg Ferrous Sulfate Tablet (65 mg Iron) on the Pharmacokinetics of 450 mg Dose of AKB-6548 in Healthy Male Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Nov 2018
Price :
$35
*
At a glance
- Drugs Vadadustat (Primary) ; Ferrous sulfate
- Indications Anaemia
- Focus Pharmacokinetics
- Sponsors Akebia Therapeutics
- 12 Apr 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 03 Jan 2015 New trial record